Introduction
============

Colorectal cancer is the third most common cancer in the world, contributing to 9.7 % (1.4 million) of the total number of new cases diagnosed in 2012 [@OR1116-1] . Colorectal polyps are considered to be precursors to colorectal cancer because cancer arises from adenomas by accumulation of mutations of cancer suppressor genes in a process known as the adenoma-carcinoma sequence [@JR1116-2] .

Both polypectomy using an electrocautery snare (hot snare polypectomy: HSP) and endoscopic mucosal resection (EMR) combined with submucosal injection [@JR1116-3] [@JR1116-4] were first reported in 1973. These endoscopic polypectomy methods have been widely used, and it has been reported that endoscopic polypectomy significantly reduces incidence and mortality of colorectal cancer [@JR1116-5] [@JR1116-6] . However, as the opportunity for endoscopic treatment has increased, complications have also increased, including delayed bleeding, perforation and post-polypectomy coagulation syndrome, [@JR1116-7] which are caused by excessive energization.

Cold polypectomy (CP) is a type of polypectomy in which polyps are physically cut without electric current. This technique was reported by Woods in 1989 as a method of eradicating diminutive polyps using biopsy forceps, [@JR1116-8] and Draganov reported that higher rates of complete resection were achieved using jumbo biopsy forceps [@JR1116-9] . This CP procedure using forceps is called cold forceps polypectomy (CFP). Moreover, Tappero first reported CP using a snare (called cold snare polypectomy: CSP) in 1992 [@JR1116-10] .

Given its safety and convenience, use of CP has spread and it has been accepted as a treatment method for all subcentimeter lesions [@JR1116-9] [@JR1116-11] [@JR1116-12] [@JR1116-13] [@JR1116-14] . However, conventional HSP and EMR still have a role because they have a potential advantage in eradicating neoplastic lesions using electrocautery. Therefore, if patients are appropriately chosen for CP and EMR appropriately, outcomes of polypectomy could be improved. Magnified endoscopy with narrow band imaging (NBI-ME) has been reported to be useful for differentiating between adenoma and non-neoplastic lesions by estimating the depth of invasion of cancer [@JR1116-15] [@JR1116-16] [@JR1116-17] [@JR1116-18] [@JR1116-19] . In 2014, a universal consensus was made on NBI-ME diagnosis, and the Japan NBI Expert Team (JNET) classification was established in which the findings of NBI-ME are categorized into four subgroups and JNET 2B and 3 are findings indicative of cancer [@JR1116-20] . We have established a treatment algorithm in which CP is applied to lesions with JNET 1 or 2A, and EMR/ HSP is used for lesions with JNET 2B. Therefore, the aim of this study was to validate the appropriateness of our algorithm and to clarify the appropriate treatment strategy for polyps less than 10 mm.

Patients and methods
====================

Study design
------------

This was a retrospective study in a tertiary hospital. Consecutive patients who underwent a colonoscopy in whom at least one colorectal polyp was detected in our department from July 2014 to October 2016 were included in this study. A total of 4668 lesions were endoscopically resected in our department during the study period. Of these, 607 lesions were excluded because their size exceeded 10 mm and 95 lesions were excluded because of pedunculated morphology. As a result, 3966 lesions were included in the data analysis. The analysis was performed on a per-lesion basis, since the outcomes of polypectomy is strongly associated with the properties of a lesion rather than those of a patient. Written informed consent was obtained from each patient included in the study. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a prior approval by the institutionʼs human research committee and approved by Tokyo medical center institutional review board on September 27th 2016.

Colonoscopy procedure
---------------------

All endoscopists participated in an intensive, 1-hour, interactive training program on endoscopic diagnosis of colorectal polyp including diagnosis of NBI with magnification by an expert endoscopist (T. U.) before performing CP. Patients underwent bowel preparation consisting of sodium picosulfate the day before colonoscopy and 2 to 3 L of polyethylene glycol solution the morning before the procedure. Colonoscopies were exclusively performed using a colonoscope with magnification capability and water irrigation function (PCF-Q260AZI or PCF-H290AZI, Olympus Co., Tokyo, Japan). After cecal intubation, all detected polyps were photographed, and their characteristics, including size, location, macroscopic type and findings of magnified endoscopy with NBI-ME, were documented. Lesion size was estimated according to comparison to endoscopic devices. Cessation of antithrombotic drugs was done in accordance with guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment published by the Japan Gastroenterological Endoscopy Society in 2014 [@JR1116-21] . Procedures were performed by three experts who had performed more than 5000 colonoscopies, four gastroenterologists who had performed 1000 to 4999 colonoscopies and six trainees who had performed fewer than 1000 colonoscopies.

Endoscopic diagnosis
--------------------

According to macroscopic findings, lesions were classified as pedunculated (0-Ip), sessile (0-Is, Isp), flat (0-IIa) or depressed (0-IIc, 0-IIa + IIc, 0-Is + IIc) according to the Paris classification [@JR1116-22] . Differentiation among non-neoplastic lesions, adenoma or cancer by macroscopic findings was made based on lesion shape and color. Hyperplastic polyps usually presented as whitish, flat, elevated lesions; adenoma exhibited a reddish color and irregular shape, and obvious depression and remarkable redness were findings suggestive of cancer. Following conventional white light imaging (WLI), we applied NBI-ME. The NBI-ME diagnosis was made according to the JNET classification, which is a universal diagnostic classification consisting of both microstructural and micro-vessel findings that was proposed in June 2014 [@JR1116-20] .

Treatment strategy based on endoscopic diagnosis
------------------------------------------------

If any lesion was found during colonoscopy, each endoscopist immediately decided whether to remove it based on real-time diagnosis including NBI-ME. All lesions suspected as neoplasms were resected. Each endoscopist chose the type of procedure for polypectomy according to macroscopic features or endoscopic diagnosis. The algorithm for the treatment strategy is shown in [Fig. 1](#FI1116-1){ref-type="fig"} .

![ Treatment strategy algorithm.](10-1055-a-0621-4445-i1116ei1){#FI1116-1}

Pedunculated polyps (Paris type 0-Ip) were resected by HSP or EMR, and CP was not attempted due to the possibility of immediate or post-procedure bleeding. The treatment choice for other polypoid lesions (Paris type 0-Is or 0-Isp) and flat, elevated polyps (Paris type 0-IIa) was determined according to NBI-ME findings. For JNET Type I polyps, those larger than 5 mm located on the right side of the colon were resected by CP because those findings suggested sessile serrated adenomas/polyps. JNET Type 2A polyps were considered low-grade adenomas and they were treated with CP. We chose CSP or CFP according to polyp size; CSP was applied to small (6 -- 9 mm) polyps, and CFP was applied to diminutive (1 -- 5 mm) polyps. As JNET Type 2B polyps were likely to be high-grade adenoma or intramucosal cancer, they were treated with EMR unless there was an obvious finding of massive submucosal invasion. JNET Type 3 polyps were surgically resected because they are likely to be invasive cancers. Depressed lesions were resected by EMR as long as invasive signs were not present on pit pattern diagnosis using crystal violet staining.

Cold polypectomy procedure
--------------------------

In CSP, a polyp with a rim of surrounding normal mucosa was ensnared with a snare (Captivator II 10 mm, Boston Scientific, Marlborough, Massachusetts, United States) and then removed by forced transection without use of electrocautery. In CFP, the polyp was removed with jumbo biopsy forceps (Radial Jaw 4 Jumbo Biopsy Forceps; Boston Scientific). After polypectomy, we created submucosal tamponade with forced water irrigation and confirmed that no residual tumor was present in post-polypectomy defects using NBI with magnification. Hemoclips were placed only in cases of continuous arterial bleeding immediately after CP.

Outcome measurements
--------------------

To validate our algorithm of treatment strategy for colorectal polyps, we divided all lesions into two groups, compliant and non-compliant, according to whether they were resected in compliance with the algorithm from the viewpoint of the choice of either HSP/EMR or CP. A lesion was categorized as compliant if it was Paris type 0-Ip or with JNET 2B/3 and resected by HSP/EMR or if was another type of lesion and was resected with CP. In this study, we didn't distinguish compliance based on f the choice of either CFP or CSP. We compared clinical characteristics, outcomes of polypectomy and pathological findings between the compliant and non-compliant group. In addition, we compared pathological findings between the JNET 1, 2A (JNET ≤ 2A) group and JNET 2B, 3 (JNET ≥ 2B) group.

Location, macroscopic type, size, endoscopic diagnosis of WLI and NBI-ME diagnosis were noted as clinical characteristics. Macroscopic type was classified as polypoid (0-Is, 0-Isp or 0-Ip of the Paris classification) or flat (0-IIa or 0-IIc of the Paris classification) [@JR1116-22] . A single endoscopist (K. A.) who was blinded to the pathological diagnosis reviewed the macroscopic type, WLI diagnosis and NBI-ME diagnosis using the recorded images. Location and size of lesions were referenced in the endoscopic record.

For polypectomy outcomes, we collected data concerning the proportion resected in a single piece, perforation and post-procedure bleeding. Bleeding was defined as an episode of obvious hematochezia with active bleeding or adherent clots on the post-polypectomy site confirmed by colonoscopy.

Pathological diagnosis was made based on the Vienna classification [@JR1116-23] . We assessed the cancer-bearing rate, proportion of submucosal cancer and proportion of negative margins as pathological findings. The cancer-bearing rate was defined as the proportion of lesions pathologically diagnosed as cancer to all resected lesions. A negative resected margin was limited to only lesions that were resected in a single piece with a tumor-free margin, and the outcome was treated as a non-negative margin when the lesion was lost or fragmented during retrieval.

The protocol compliance rate was defined as the proportion of polyps subjected to a polypectomy method prescribed by the protocol relative to all polyps. Moreover, the protocol compliance rate was analyzed by dividing the polypectomy method into HSP/EMR and CP groups.

Statistical analysis
--------------------

Wilcoxon's rank sum test and Fisher's exact test were used to compare continuous and categorized factors. Outcomes of polypectomy are presented as percentages with 95 % confidence intervals. Statistical significance was defined as *P*  \< 0.05. Data analysis was performed using JMP software (ver. 11.1.1, SAS Institute Inc., Cary, North Carolina, United States).

Results
=======

Clinical characteristics
------------------------

A flow diagram of included lesions is shown in [Fig. 2](#FI1116-2){ref-type="fig"} . The compliant group included 3401 lesions and the non-compliant group included 565 lesions. The proportion of lesions resected in compliance with the algorithm was 85.8 %. The most common reason for violation was application of EMR/HSP for lesions with JNET ≤ 2A (99.7 %). The clinical characteristics of the examined lesions are described in [Table 1](#TB1116-1){ref-type="table"} . Approximately 60 % of lesions were located in the right colon. Over 90 % of the lesions had polypoid morphology. Mean polyp size was 4.6 ± 1.7 mm. Approximately 99 % of lesions were classified as JNET 2A. When the study population was divided into the compliant and non-compliant groups, significantly more lesions were located on the right side and lesion size was significantly smaller in the compliant group. The main reason for violating the algorithm was application of EMR/HSP for JNET ≤ 2A and the majority of the non-compliant group was resected with EMR/HSP ( [Table 2](#TB1116-2){ref-type="table"} ).
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###### Clinical characteristic of the lesions (n = 3966).

  --------------------------------- ------------------------------------------------------------------------------ -------------------------------
  Location                          Cecum Ascending colon Transverse colon Descending colon Sigmoid colon Rectum    7 % 24 % 26 %  9 % 24 % 10 %
  Macroscopic type                  Sessile Flat Depressed                                                         93 %  6 %  1 %
  Size                              Mean ± SD                                                                       4.6  ± SD1.7 mm
  Japan NBI Expert classification   1 2A 2B 3                                                                       1.7 % 97.7 %  0.6 %  0.03 %
  --------------------------------- ------------------------------------------------------------------------------ -------------------------------

###### Characteristics of lesions in compliant and non-compliant groups.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Factors                Compliant (N = 3401)   Non-compliant (N = 565)                                                                                 *P* value                                                                                               
  ---------------------- ---------------------- ------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- -----------------------------------------------
  Location               Right side             60 %                                                                                                    47 %                                                                                                     \< 0.01 [\*](#FN1116-1){ref-type="table-fn"}

  Macroscopic type       Polypoid               93 %                                                                                                    93 %                                                                                                    0.98

  Size                   Median \[range\]        4 [@JR1116-2] [@JR1116-3] [@JR1116-4] [@JR1116-5] [@JR1116-6] [@JR1116-7] [@JR1116-8] [@JR1116-9] mm    7 [@JR1116-2] [@JR1116-3] [@JR1116-4] [@JR1116-5] [@JR1116-6] [@JR1116-7] [@JR1116-8] [@JR1116-9] mm    \< 0.01 [\*](#FN1116-1){ref-type="table-fn"}

  WLI diagnosis          Adenoma                98 %                                                                                                    95 %                                                                                                     \< 0.01 [\*](#FN1116-1){ref-type="table-fn"}

  JNET classification     ≤ 2A  ≥ 2B            99.3 %  0.68 %                                                                                          99.8 %  0.18 %                                                                                          0.24

  Endoscopic treatment   CP EMR/HSP             99.0 %\                                                                                                  0.35 %\                                                                                                 \< 0.01 [\*](#FN1116-1){ref-type="table-fn"}
                                                 1.0 %                                                                                                  99.6 %                                                                                                  
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

WLI, white light imaging; JNET, Japan NBI Expert Team

statistically significant

Outcomes of polypectomy in compliant and non-compliant group
------------------------------------------------------------

Outcomes of endoscopic treatment in both the compliant and non-compliant groups are described in [Table 3](#TB1116-3){ref-type="table"} . Resection in a single piece was achieved in more than 97 % of lesions in both groups. Perforation did not occur in either group. Delayed bleeding occurred only in the non-compliant group, and there was a significant difference in the proportion of lesions with delayed bleeding.

###### Outcomes of endoscopic treatment in compliant and non-compliant groups.

  --------------------------------------------------------------------------------------------------------------------------------------
  Factors                        Compliant\                  Non-compliant\              *P* value
                                 (N = 3401)                  (N = 565)                   
  ------------------------------ --------------------------- --------------------------- -----------------------------------------------
  Resection in a single piece\   98.2 % \[97.7 -- 98.6 %\]   97.0 % \[95.2 -- 98.1 %\]   0.068
  \[95 % CI\]                                                                            

  Perforation \[95 % CI\]         0 % \[0 -- 0.11 %\]         0 % \[0 -- 0.68 %\]        

  Bleeding \[95 % CI\]            0 % \[0 -- 0.11 %\]         0.53 % \[0.18 -- 1.5 %\]    \< 0.01 [\*](#FN1116-2){ref-type="table-fn"}
  --------------------------------------------------------------------------------------------------------------------------------------

statistically significant

Comparison of pathological findings between JNET ≤ 2A and ≥ 2B group
--------------------------------------------------------------------

Pathological findings of the resected specimens according to NBI-ME findings are shown in [Table 4](#TB1116-4){ref-type="table"} . There were many more lesions diagnosed as cancer pathologically in the JNET ≥ 2B group (38 %) than in the JNET ≤ 2A group (0.36 %). Similarly, the proportion of submucosal cancer was much higher in the JNET ≥ 2B group (4.2 % vs 0.03 %). With regard to the incidence of negative resection margins, it was significantly higher in the compliant group (91 % vs 64 %).

###### Pathological findings of lesions ≤ JNET 2A and ≥ JNET 2B.

  Factors                                        ≤ JNET 2A                    ≥ JNET 2B               *P* value
  --------------------------------------------- ---------------------------- ------------------------ -----------------------------------------------
  Cancer-bearing rate \[95 % CI\]                0.36 % \[0.21 -- 0.60 %\]   38 % \[21 -- 57 %\]       \< 0.01 [\*](#FN1116-3){ref-type="table-fn"}
  Proportion of Submucosal cancer \[95 % CI\]    0.03 % \[0.00 -- 0.14 %\]    4.2 % \[0.7 -- 20 %\]   0.012 [\*](#FN1116-3){ref-type="table-fn"}
  Negative margin \[95 % CI\]                   64 % \[62 -- 65 %\]          91 % \[72 -- 97 %\]       \< 0.01 [\*](#FN1116-3){ref-type="table-fn"}

statistically significant

Comparison of outcomes between CP and EMR/HSP
---------------------------------------------

Resection in a single piece was achieved in approximately 98 % of lesions in both groups. Perforation did not occur in either group. Delayed bleeding occurred in three lesions (0.50 %, 95 %CI 0.17 -- 1.5 %) resected by EMR/HSP, whereas no lesion treated with CP was associated with delayed bleeding. The cancer-bearing rate was approximately 10-fold higher for EMR/HSP than for CP (2.5 % vs 0.24 %, *P*  \< 0.01). Submucosal cancer was found only in the EMR group. The incidence of negative resection margins was significantly higher in the EMR group (86 % vs 60 %, *P*  \< 0.01).

Discussion
----------

In this retrospective study, we analyzed 4061 endoscopically resected consecutive polyps. Post-polypectomy bleeding did not occur at all in 3401 polyps resected with CP, and the proportion of post-polypectomy bleeding of CP was significantly lower than that for HSP/EMR. However, the negative margin rate for CP was 60 %, which was significantly lower than that for HSP/EMR. According to our treatment strategy algorithm, the cancer-bearing rate for HSP/EMR was 10-fold higher than that for CP.

Previous studies have reported that CP prevented post-polypectomy bleeding [@JR1116-8] [@JR1116-9] [@JR1116-10] . Recently, Horiuchi reported that CSP did not cause post-polypectomy bleeding in patients receiving anticoagulant treatment, and a significant difference was observed between CSP and EMR [@JR1116-13] . These results suggest that CP would reduce post-polypectomy bleeding as well as perforation or post-polypectomy electrocoagulation syndrome, although electrocoagulation is believed to prevent bleeding immediately after polypectomy. The results of our study showed that post-polypectomy bleeding was not found in more than 3000 consecutive polyps resected by CP, which provides evidence of the safety of CP.

Despite its safety, some concerns exist regarding CP. One concern is the inferiority of the curability of polyps removed using CP. The negative margin rate for CP was only 60 %, which was significantly lower than that for HSP/EMR (approximately 85 % in our study). Not using an electric current leads to fewer complications but increases the risk of local residue due to absence of a burning effect. Furthermore, maintaining sufficient margins is difficult in CP because a polyp cannot be physically removed, as opposed to EMR, if excess surrounding mucosa is captured. Another concern is the difficulty of pathological diagnosis of specimens resected by CP. Tutticci reported that resection depth with CSP was relatively shallow, with a shallow layer of submucosa and occasionally muscularis mucosa [@JR1116-24] . Specimens were thin and fragile and were therefore easily fragmented during retrieval by suctioning through the working channel of the colonoscope. It is also difficult to diagnose invasive cancer when a sufficient depth of the submucosal layer is not resected. Therefore, EMR/HSP is much better than CP in terms of clearness of margin resection and precise histological diagnosis.

According to previous reports, the proportion of invasive cancer in polyps smaller than 10 mm ranges from 0.2 to 0.9 % [@JR1116-25] [@JR1116-26] . The proportion of invasive cancer in our study was 0.27 %, which was consistent with previous studies. These proportions were low; however, they were not negligible when considering the disadvantage of CP mentioned above. Using macroscopic findings and the JNET classification, we established an algorithm for choosing the type of endoscopic treatment for small colorectal polyps. In this retrospective study, we analyzed 3966 endoscopically resected consecutive polyps to validate our algorithm for treatment strategy for small colorectal polyps. Post-polypectomy bleeding did not occur at all in 3401 polyps resected in compliance with our algorithm, and the proportion of post-polypectomy bleeding with CP was significantly lower than that in the non-compliant group. Moreover, both the cancer-bearing rate and proportion of submucosal cancer, and proportion of the lesion with pathological tumor-free margin were much higher in the JNET ≥ 2B group. These results show our algorithm effectively picked up high-risk lesions and EMR/HSP (which is better in terms of clearness margin resection) or CP (which is better in terms of less complications) was appropriately chosen with significant decrease in complications.

The current study has several limitations due its single-center retrospective design. First, we analyzed only lesions that were endoscopically resected; therefore, we cannot eliminate a certain degree of selection bias. For example, small lesions surgically resected due to a suspicion of deep invasion were excluded from data analysis. Second, the compliance rate for treatment choices in this study was less than 50 %. However, concerning the choice between CP and EMR, the compliance rate was approximately 85 %. Although the results of our study should be interpreted carefully due to these limitations, our results, based on over 4000 polyps, indicate that CP should be considered as a treatment option.

Conclusion
==========

In conclusion, this large-scale retrospective study demonstrated that our algorithm for treatment of small polyps based on endoscopic diagnosis, including NBI-ME, would be valid. Although CP is suitable for a large proportion of small polyps due to its safety, EMR should still be used for an accurate pathological diagnosis when polyps are suspected as cancer by NBI-ME.
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